The safety of levofloxacin in elderly patients on warfarin.
Stroud
Lynfa F
LF
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Mamdami
Muhammad M
MM
Kopp
Alex
A
Bell
Chaim M
CM
D000208:Acute Disease; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D016022:Case-Control Studies; D004347:Drug Interactions; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D064704:Levofloxacin; D008297:Male; D016017:Odds Ratio; D015242:Ofloxacin / Q000009:adverse effects*; D009864:Ontario; D013927:Thrombosis / Q000517:prevention & control; D014859:Warfarin / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D014859:Warfarin; D064704:Levofloxacin; D015242:Ofloxacin